Principia Biopharma Inc (PRNB) Return on Equity ROE from the second quarter 2020 to second quarter 2019 and annually, average high and low, overall ranking from Jun 30 2020 to Jun 30 2019 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Principia Biopharma Inc   (NASDAQ: PRNB)

Principia Biopharma Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Principia Biopharma Inc in the second quarter 2020?
Principia Biopharma Inc recorded a cumulative net loss of $-15 million during 12 months ending in the second quarter 2020, resulting in a negative return on equity (ROE) of -5.06%.

Within the Major Pharmaceutical Preparations industry Principia Biopharma Inc achieved the highest return on equity. While the total ranking for ROE unchanged, relative to the first quarter 2020 at no. .

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Jun 30 2020)
II. Quarter		 (Mar 31 2020)
I. Quarter		 (Dec 31 2019)
IV. Quarter		 (Sep 30 2019)
III. Quarter		 (Jun 30 2019)
II. Quarter
Y / Y Equity Change 105.91 % 108.47 % 111.34 % -4.03 % -
Y / Y Net Income Change 51.93 % - 207.86 % - 295.94 %
Net Income (TTM) in Millions -15 -19 0 -19 9
Return On Equity (TTM) -5.06 % -7.42 % 0 % -11.95 % 5.76 %
PRNB's Total Ranking # # # # #
Equity (TTM) in Millions 351 331 359 153 171
Seq. Equity Change 6.03 % -7.67 % 135.13 % -10.55 % 7.35 %
Seq. Net Income Change - - - - -

Back to PRNB Management Effectiveness >> PRNB's 5 Years Annual ROE >> Compare PRNB ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Equity Statistics
High Average Low
0 %
0 %
0 %
 





PRNB Annual Return On Equity (Dec 31 2019)
2019		 (Dec 31 2018)
2018


Total Equity in Millions 359 170 0 0 0
Y / Y Equity Change 111.34 % - - - -
Net Income in Millions 0 18 0 0 0
Y / Y Net Income Change - - - - -
Return On Equity 0 % 10.7 % - - -

Back to PRNB Management Effectiveness >> PRNB's 5 Years Annual ROE >> Compare PRNB ROE to its Competitors




More Return On Equity Ratios
Major Pharmaceutical Preparations Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
PRNB's' Return on Equity at Yahoo Finance
PRNB's Roe Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for PRNB's Competitors
Subscribers only: Roe for Principia Biopharma Inc 's Suppliers
Subscribers only: Return On Equity for PRNB's Customers




Companies with similar Return On Equity at Jun 30 2020, within Healthcare Sector ROE

Date modified: 2026-09-26T07:34:42+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.